Hydroxychloroquine Synergizes With The PI3K Inhibitor BKM120 to Exhibit Antitumor Efficacy Independent of Autophagy

Xin Peng(The University of Texas MD Anderson Cancer Center), Kong De(Tianjin Medical University)

Research Square

July 13, 2021

10.21203/rs.3.rs-691658/v1

Cited by 0

Related Papers

Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy

|Journal of Experimental & Clinical Cancer Research|2021|56

Jab1 regulates HRR mRNA stability to modulate PARP inhibitor sensitivity in triple-negative breast cancer

|Molecular Cancer|2025|3